Fierce Pharma Layoff Tracker 2025. Fierce Pharma Layoff Tracker 2025 Sana Ava Companies like X4 Pharmaceuticals, Viracta Therapeutics, and Kyowa Kirin faced significant workforce reductions In a statement to Fierce Pharma, a company spokesperson confirmed the cuts and said that it will primarily affect commercial field sales teams for Xolair, Tafinlar and Mekinist
Fierce Pharma Layoffs 2025 Rami Belle from ramibele.pages.dev
Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. Biogen has also been undergoing far-reaching layoffs since 2023 and reduced its R&D staff in January by an undisclosed amount to better align with a renewed focus on preclinical candidates
Fierce Pharma Layoffs 2025 Rami Belle
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker
Forbes Layoff Tracker 2025 Xavier Faris. Sales for Leqembi grew in 2024 and were on track to hit $279 million by the end of the year, Eisai reported in November Fierce Biotech Layoff Tracker 2025: Vaxart, Elevation & more As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team
Fierce Pharma Layoff Tracker 2024 Greta Melinda. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data